Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.0500 (-0.14%) ($6.8500 - $7.1800) on Fri. May. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 33.68% (three month average) | RSI | 92 | Latest Price | $7.0500(-0.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.6% a day on average for past five trading days. | Weekly Trend | CAPR advances 63.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) OIH(36%) CEMB(35%) XLC(35%) XOP(34%) PEJ(33%) | Factors Impacting CAPR price | CAPR will decline at least -16.84% in a week (0% probabilities). VXX(-18%) VIXM(-16%) UUP(-15%) UNG(-8%) TLT(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -16.84% (StdDev 33.68%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
5 Day Moving Average | $7.01(0.57%) | 10 Day Moving Average | $6.35(11.02%) | 20 Day Moving Average | $4.16(69.47%) | To recent high | -17.1% | To recent low | 3.7% | Market Cap | $139m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |